新規ドラッグデリバリーシステム市場：投与経路、モード、エンドユーザー別-2024～2030年の世界予測

新規ドラッグデリバリーシステム市場規模は2023年に138億3,000万米ドルと推計され、2024年には150億米ドルに達し、CAGR 9.17%で2030年には255億7,000万米ドルに達すると予測されています。

新規ドラッグデリバリーシステム（NDDS）とは、従来とは異なる方法で体内に送達できる医薬品を処方するために医薬品で使用される高度な方法と技術を指します。調査手法には、有効性を高め、薬物放出を制御し、患者のコンプライアンスを向上させるために、医薬化合物を体内の特定部位に輸送するように設計された多様な技術や手法が含まれます。慢性疾患の蔓延、老人人口の大幅な増加、薬物放出制御技術の進歩が新規ドラッグデリバリーシステム市場の成長に影響を与えています。新規ドラッグデリバリーシステムに対する政府の承認が市場の成長を加速させています。新規ドラッグデリバリーシステムに関連する既存の制限、合併症、治療薬や薬剤の送達に必要な専門知識は、拡張性や広範な使用を制限する可能性があります。新規ドラッグデリバリーシステムの開発における継続的な進歩や自己注射デバイスの採用の増加は、市場の成長機会をもたらすと期待されています。

投与経路：慢性疾患管理における注射薬デリバリーシステムの採用増加

注射剤ドラッグデリバリーシステムは、体内循環に薬剤を直接デリバリーするように設計されています。これらのシステムは一般的に、迅速な作用発現、経口バイオアベイラビリティの低い薬物、標的薬物送達に好まれています。経口ドラッグデリバリーシステムは最も一般的な経路であり、投与のしやすさ、患者のコンプライアンス、費用対効果の面で好まれています。このカテゴリーの技術革新は、溶解性と吸収性の向上、放出制御、作用部位への正確なターゲティングを目指し、副作用を最小限に抑えることを目的としています。肺ドラッグデリバリーシステムは、呼吸器疾患の局所治療や特定の薬剤の全身デリバリーに使用されます。ネブライザー、定量吸入器、ドライパウダー吸入器など、非侵襲的で迅速な全身吸収が可能です。経皮ドラッグデリバリーシステムは、皮膚から薬剤を投与し、全身に作用させる。経口経路が不適当な場合、あるいは初回通過代謝を避けるために好まれ、パッチ、ゲル、マイクロニードル技術などが進歩しました。比較分析によると、注射剤は薬物のバイオアベイラビリティと標的デリバリーの点で優れているが、患者の利便性では遅れています。経口剤は利便性とコスト効率に優れるが、バイオアベイラビリティは異なります。一方、経皮システムは持続的なデリバリーと良好な患者コンプライアンスを提供するが、効果的にデリバリーできる薬剤の種類には限界があります。

エンドユーザー：予算の制約やより多くの患者層に対応する必要性から、病院での新規ドラッグデリバリーシステムの使用が増加

病院は新規ドラッグデリバリーシステムの最大のセグメントです。その最大の関心事は、患者中心の治療と治療成績の向上です。病院は、安全かつ効果的で、薬剤放出を高度にコントロールできるドラッグデリバリーシステムを求めています。研究センターは、ドラッグデリバリーシステムの革新と最先端技術を優先しています。研究センターは、薬剤の正確な標的化と放出を可能にする高度なドラッグデリバリー・メカニズムに重点を置いています。専門クリニック部門は、特定の医療分野や疾患に特化したドラッグデリバリーシステムを求めています。専門クリニックは、治療結果を最適化する疾患特異的なデリバリーシステムを好みます。どのセグメントもイノベーションを重視するが、研究センターは最先端のデリバリー・メソッドを重視し、次に疾患特有のイノベーションを必要とする専門クリニックが続く。病院は、モニタリングとコンプライアンスを向上させるため、既存の医療情報テクノロジーとシームレスに統合するシステムを強く求めています。

地域別の洞察

南北アメリカの新規ドラッグデリバリーシステム（NDDS）市場は、個別化医療に重点を置いた強力な技術進歩と研究開発への多額の投資によって牽引されています。主要な製薬企業の存在と確立されたヘルスケアインフラが、この地域の先駆的な地位に貢献しています。米国のFDAによる規制の枠組みは、革新的なドラッグデリバリーソリューションの導入・採用に適した環境を整えています。南米のNDDS市場は、認知度の向上とヘルスケア支出の増加により台頭しつつあります。欧州は、政府の強力な支援と質の高いヘルスケアシステムに支えられ、NDDSの導入が最も進んでいます。一方、中東とアフリカも、戦略的パートナーシップとヘルスケア分野への投資の増加により、その進歩に適応しつつあります。アジア太平洋地域は、経済成長とヘルスケア投資の増加により、NDDS市場で著しい成長を遂げています。技術力と多額のヘルスケア支出を持つ中国と日本が主要国です。さらに、インドと東南アジアの製薬セクターの成長は、NDDS市場の拡大に大きく貢献しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは新規ドラッグデリバリーシステム市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、新規ドラッグデリバリーシステム市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.新規ドラッグデリバリーシステム市場の市場規模および予測は？

2.新規ドラッグデリバリーシステム市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.新規ドラッグデリバリーシステム市場の技術動向と規制枠組みは？

4.新規ドラッグデリバリーシステム市場における主要ベンダーの市場シェアは？

5.新規ドラッグデリバリーシステム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と高齢者人口の大幅な増加
    • 薬物放出制御技術の進歩
    • 新規ドラッグデリバリーシステムの政府承認
  • 抑制要因
    • 新しいドラッグデリバリーシステムに関連する既存の制限
  • 機会
    • 新規ドラッグデリバリーシステムの開発の継続的な進歩
    • 自己注射デバイスの採用増加
  • 課題
    • 治療薬や薬剤の投与に必要な合併症と専門知識
• 市場セグメンテーション分析
  • 投与経路：慢性疾患管理のための注射ドラッグデリバリーシステムの採用増加
  • エンドユーザー：予算の制約とより多くの患者に対応する必要性により、病院での新規ドラッグデリバリーシステムの使用が増加しています。
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 新規ドラッグデリバリーシステム市場：投与経路別

• 注射ドラッグデリバリーシステム
• 経口ドラッグデリバリーシステム
• 肺ドラッグデリバリーシステム
• 経皮ドラッグデリバリーシステム

第7章 新規ドラッグデリバリーシステム市場モード別

• 制御ドラッグデリバリーシステム
• 調節ドラッグデリバリーシステム
• 標的ドラッグデリバリーシステム

第8章 新規ドラッグデリバリーシステム市場：エンドユーザー別

• 病院
• 研究センター
• 専門クリニック

第9章 南北アメリカの新規ドラッグデリバリーシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の新規ドラッグデリバリーシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの新規ドラッグデリバリーシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • 新しいドラッグデリバリーのワンストップショップ
  • Viridian Therapeutics、ドラッグデリバリーの革新企業Enable Injectionsとの提携を発表
  • キンデバ・ドラッグデリバリーがサミット・バイオサイエンスを買収

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. NOVEL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. NOVEL DRUG DELIVERY SYSTEMS MARKET DYNAMICS
• FIGURE 7. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. NOVEL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. NOVEL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 53. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 54. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 55. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 56. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 57. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 58. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 88. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 89. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 90. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 91. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 94. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 95. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 96. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 97. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 98. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 197. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 198. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 199. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 200. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 201. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 222. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 223. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 224. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 225. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 228. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 229. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 230. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 231. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 232. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 287. NOVEL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 288. NOVEL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

[190 Pages Report] The Novel Drug Delivery Systems Market size was estimated at USD 13.83 billion in 2023 and expected to reach USD 15.00 billion in 2024, at a CAGR 9.17% to reach USD 25.57 billion by 2030.

Novel drug delivery systems (NDDS) refer to the advanced methods and technologies used in pharmaceuticals to formulate medicines that can be delivered to the body in non-traditional ways. The market for novel drug delivery systems encompasses diverse technologies and methodologies designed to transport pharmaceutical compounds to specific parts of the body to enhance efficacy, control drug release, and improve patient compliance. The prevalence of chronic diseases, a significant rise in the geriatric population, and advancements in controlled drug release technologies are influencing the growth of the novel drug delivery systems market. Government approvals for novel drug delivery systems are accelerating the market's growth. Existing limitations associated with novel drug delivery systems, complications, and expertise required in delivering therapeutics and drugs may limit scalability and widespread usage. Ongoing advancements in developing novel drug delivery systems and the rising adoption of self-injectable devices are expected to provide growth opportunities in the market.

Route of Administration: Rising adoption of injectable drug delivery systems for chronic disease management

Injectable drug delivery systems are designed for direct delivery of drugs into the body's circulation. These systems are typically preferred for rapid onset of action, for drugs with poor oral bioavailability, and for targeted drug delivery. Oral drug delivery systems are the most common route, favored for ease of administration, patient compliance, and cost-effectiveness. Innovations in this category aim to improve solubility and absorption, controlled release, and precise targeting to the site of action to minimize side effects. Pulmonary drug delivery systems are employed for localized treatment of respiratory diseases and systemic delivery of certain drugs. They offer non-invasive rapid systemic absorption, highlighting nebulizers, metered-dose inhalers, and dry powder inhalers. Transdermal drug delivery systems administer drugs through the skin for systemic effects. Preferred when oral routes are unsuitable or to avoid first-pass metabolism, advancements include patches, gels, and microneedle technologies. A comparative analysis reveals that injectables excel in terms of drug bioavailability and targeted delivery but lag in patient convenience. Oral systems offer convenience and cost efficiency, yet vary in bioavailability. Pulmonary methods provide fast absorption and are relatively easy to use, while transdermal systems offer sustained delivery and good patient compliance, though with potential limits on the types of drugs that can be effectively delivered.

End-User: Increasing use of novel drug delivery systems in the hospital due to budget constraints and the necessity to cater to a larger patient base

Hospitals represent the largest segment of novel drug delivery systems. Their primary concern is delivering patient-centered care with improved outcomes. Hospitals seek drug delivery systems that are safe and effective with a high degree of control over drug release. Research centers prioritize innovation and cutting-edge technologies in drug delivery systems. They focus on advanced drug delivery mechanisms that allow precise targeting and release of drugs. The specialty clinics segment seeks specialized and targeted drug delivery systems that support their focus on particular medical disciplines or diseases. Specialty clinics prefer disease-specific delivery systems that optimize therapeutic outcomes. While all segments value innovation, research centers emphasize cutting-edge delivery methods, followed by specialty clinics requiring disease-specific innovations. Hospitals have a strong need for systems that integrate seamlessly with existing health information technologies for better monitoring and compliance.

Regional Insights

The novel drug delivery systems (NDDS) market in the Americas is driven by robust technological advancements and significant investments in research and development, with a strong focus on personalized medicine. The presence of key pharmaceutical companies and a well-established healthcare infrastructure contribute to the pioneering position of this region. The regulatory framework facilitated by the FDA in the United States sets a conducive environment for introducing and adopting innovative drug delivery solutions. South America's market for NDDS is emerging with growing awareness and increasing healthcare expenditure. Europe has the highest adoption of NDDS, backed by strong governmental support and high-quality healthcare systems. In contrast, the Middle East and Africa are also adapting to the advancements owing to increasing strategic partnerships and investments in healthcare sectors. The Asia-Pacific region is witnessing significant growth in the NDDS market attributed to growing economies and increasing healthcare investments. Due to their technological capabilities and substantial healthcare spending, China and Japan are major countries. Additionally, the growing pharmaceutical sectors in India and Southeast Asia are contributing significantly to the expansion of the NDDS market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Novel Drug Delivery Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Novel Drug Delivery Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Novel Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca Plc, Bayer AG, Boston Scientific Corporation, Bristol Myers Squibb Company, Cospheric LLC, Enable Injections, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Mo-Sci Corporation, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., Societal CDMO, Spectrum Pharmaceuticals, Inc., Terumo Medical Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Novel Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Route of Administration
  • Injectable Drug Delivery Systems
  • Oral Drug Delivery Systems
  • Pulmonary Drug Delivery Systems
  • Transdermal Drug Delivery Systems

• Mode
  • Controlled Drug Delivery Systems
  • Modulated Drug Delivery Systems
  • Targeted Drug Delivery Systems

• End-User
  • Hospital
  • Research Centers
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Novel Drug Delivery Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Novel Drug Delivery Systems Market?

3. What are the technology trends and regulatory frameworks in the Novel Drug Delivery Systems Market?

4. What is the market share of the leading vendors in the Novel Drug Delivery Systems Market?

5. Which modes and strategic moves are suitable for entering the Novel Drug Delivery Systems Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of Chronic Diseases and Significant Rise in Geriatric Population
    • 5.1.1.2. Advancements in Controlled Drug Release Technologies
    • 5.1.1.3. Government Approvals for Novel Drug Delivery Systems
  • 5.1.2. Restraints
    • 5.1.2.1. Existing Limitations Associated with Novel Drug Delivery System
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Advancements for Development of Novel Drug Delivery Systems
    • 5.1.3.2. Rising Adoption of Self-Injectable Devices
  • 5.1.4. Challenges
    • 5.1.4.1. Complications and Expertise Required in Delivering Therapeutics and Drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Route of Administration: Rising adoption of injectable drug delivery systems for chronic disease management
  • 5.2.2. End-User: Increasing use of novel drug delivery systems in the hospital due to budget constraints and the necessity to cater to a larger patient base
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Novel Drug Delivery Systems Market, by Route of Administration

• 6.1. Introduction
• 6.2. Injectable Drug Delivery Systems
• 6.3. Oral Drug Delivery Systems
• 6.4. Pulmonary Drug Delivery Systems
• 6.5. Transdermal Drug Delivery Systems

7. Novel Drug Delivery Systems Market, by Mode

• 7.1. Introduction
• 7.2. Controlled Drug Delivery Systems
• 7.3. Modulated Drug Delivery Systems
• 7.4. Targeted Drug Delivery Systems

8. Novel Drug Delivery Systems Market, by End-User

• 8.1. Introduction
• 8.2. Hospital
• 8.3. Research Centers
• 8.4. Specialty Clinics

9. Americas Novel Drug Delivery Systems Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Novel Drug Delivery Systems Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Novel Drug Delivery Systems Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Novel drug delivery one-stop shop
  • 12.3.2. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
  • 12.3.3. Kindeva Drug Delivery acquires Summit Biosciences

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio